Your browser doesn't support javascript.
loading
Performing Cost-Effectiveness Analyses to Support Policy Making: Key Lessons From the Assessment of Aducanumab.
Campbell, Jonathan D; Whittington, Melanie D; Pearson, Steven D.
Affiliation
  • Campbell JD; From the Institute for Clinical and Economic Review, Boston, MA. jcampbell@icer.org.
  • Whittington MD; From the Institute for Clinical and Economic Review, Boston, MA.
  • Pearson SD; From the Institute for Clinical and Economic Review, Boston, MA.
Neurology ; 98(9): 360-365, 2022 03 01.
Article in En | MEDLINE | ID: mdl-35022308
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Policy Making / Research Personnel Type of study: Evaluation_studies / Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Neurology Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Policy Making / Research Personnel Type of study: Evaluation_studies / Health_economic_evaluation / Prognostic_studies Limits: Humans Language: En Journal: Neurology Year: 2022 Document type: Article Affiliation country: